Clinical Trial Detail

NCT ID NCT02116959
Title Alternating Systemic Chemotherapy and Intra-Arterial Melphalan Chemotherapy in Children With Intra-Ocular Retinoblastoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Francisco
Indications

intraocular retinoblastoma

Therapies

Carboplatin + Etoposide + Melphalan + Vincristine Sulfate

Age Groups: child

No variant requirements are available.